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Abstract
Introduction: A sweeping beam technique for total body irradiation in standard treatment rooms and for standard
linear accelerators (linacs) is introduced, which does not require any accessory attached to the linac. Lung shielding
is facilitated to reduce the risk of pulmonary toxicity. Additionally, the applicability of a commercial radiotherapy
planning system (RTPS) is examined.
Material and Methods: The patient is positioned on a low couch on the floor, the longitudinal axis of the body in
the rotational plane of the linac. Eight arc fields and five additional fixed beams are applied to the patient in supine
and prone position respectively. The dose distributions were measured in a solid water phantom and in an
Alderson phantom. Diode detectors were calibrated for in-vivo dosimetry. The RTPS Oncentra was employed for
calculations of the dose distribution.
Results: For the cranial 120 cm the longitudinal dose profile in a slab phantom measured with ionization chamber
varies between 94 and 107 % of the prescription dose. These values were confirmed by film measurements and
RTPS calculations. The transmittance of the lung shields has been determined as a function of the thickness of the
absorber material. Measurements in an Alderson phantom and in-vivo dosimetry of the first patients match the
calculated dose.
Discussion and conclusion: A treatment technique with clinically good dose distributions has been introduced,
which can be applied with each standard linac and in standard treatment rooms. Dose calculations were performed
with a commercial RTPS and should enable individual dose optimization.
Keywords: Total body irradiation, Sweeping beam technique, Lung shielding, Dosimetry, 3D treatment planning
Background
Total body irradiation (TBI) plays a prominent role espe-
cially in the myeloablative conditioning prior to
hematopoietic stem cell transplantation [1]. Many differ-
ent schemes regarding the total dose, the fractionation
and the dose rate are reported [2, 3]. However, 12 Gy in 6
fractions on 3 days is a very common myeloablative condi-
tion scheme [3, 4]. From 1995 to 2013 at our department
different schemes have been applied [5] using a sweeping
beam technique as described by Müller [6]. This tech-
nique not only used a gravity oriented shaped filter to
compensate the effects of inverse square variation of the
fluence with distance as it has later been investigated by
Chui et al. [7], but also allowed the application of a set of
lung shields close to the collimator.
The aim of this study was to establish a treatment pro-
cedure with similar parameters, when the linacs which
had been employed for this sweeping beam technique
had to be replaced [8, 9]. No accessory should be at-
tached directly to the machine to avoid a certification
process for in-house developed equipment [10]. Lung
shielding should be facilitated to reduce the pulmonary
toxicity [2, 11] as it was possible with the former tech-
nique. Abandoning of the gravity oriented accessory was
a precondition to enable the calculation of the dose dis-
tribution with a commercial RTPS in clinical routine
[12]. Although the application of a commercial RTPS is
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still quite uncommon in TBI with Linacs, as the tech-
nical conditions cannot be modelled for many of the ap-
plied techniques, single cases have been reported earlier
[12–15]. In the recent years further adaptions of RTPS
for TBI have been presented [16, 17].
This study presents the measurements required for the
introduction of the new technique and the results of the
in-vivo dosimetry of the first plans.
Methods
Linac, couch and patient positioning
Two linacs of type Elekta Synergy™ with Agility™ head
(Elekta Ltd., Crawley, UK) and photon energies of 6 and
15 MV and electron energies of 6, 8, 10, 12 and 15 MeV
were used for this study. Both linacs have been matched
[18] and conform the requirement of a back-up concept,
guaranteeing the completion of the treatment in time in
case of machine breakdown [11, 19].
The patient is positioned on a low couch on the floor
in supine and prone position, the longitudinal axis in the
rotation plane of the gantry (Fig. 1). The positioning is
supported by a soft mask allowing free air flow in the
prone direction. The couch top is located 117.5 cm
below the isocenter. A plate of Makrolon® polycarbonate
of 10 mm thickness is placed on a stand above the pa-
tient to reduce the buildup effect in the patient [11]. The
distance between the couch and the polycarbonate plate
is 33 cm. The plate also serves as tray for the lung
shields. The top of the patient’s head is always 60 cm
from the vertical isocenter plane and is represented by
the longitudinal position l = 0 cm. The dose reference
point was defined on the vertical axis through the iso-
center in the middle of the diameter of the patient or
phantom at l = 60 cm. In most cases this is close to the
umbilical transverse plane as a quite common reference
point [19–21]. The position of the feet depends on the
patient’s body length.
The low diameter in the cervical region is partially
compensated in prone and supine positioning by a bolus
of plastic modelling mass.
Treatment fields
The photon beam energy chosen for TBI is 6 MV as ra-
ther common [11]. The main dose contribution is given
by rotational fields (arcs) alternating from 310° to 70°
clockwise and reverse. A collimator angle of 90° ensures
a constant field width of 10 cm at the isocenter in the
sweeping direction limited by the solid jaws. The multi-
leaf collimator is set to an opening of 40 cm to exceed
the couch width. A number of eight arcs per patient
position and a dose rate of 300 monitor units (MU) per
minute has been chosen to achieve a low mean lung
dose rate [21] which has been discussed as a parameter
to reduce pulmonary toxicity [20, 22–24]. For the com-
pensation of the effects of inverse square variation of the
fluence with distance, additional fields are required in
the cranial and caudal direction, partially with wedge,
the toe directed to the more distant areas. The parame-
ters of these distance compensating fields are given in
Table 1. The MU are kept constant as the diameters of
the heads and legs vary less than in the trunk region.
Patients, whose lungs are shielded, are treated with
electron fields in the shielded region to achieve the full
dose to the thoracic wall. The energy of the electron
fields is chosen depending on the thickness of the thor-
acic wall. The electron applicator 25 × 25 cm2 is
equipped with individually shaped apertures and is ap-
plied in source skin distance of 110 cm.
Measurements, phantoms and dosimeters
A solid phantom of water equivalent material (RW3,
PTW Freiburg, Germany) was composed of slabs of
1 cm to cuboids of 30 cm width, 90 cm length, and 11–
29 cm height, thus fulfilling minimum dimension re-
quirements [20, 21]. From position l = 135 cm to higher
values, which represents the region of the legs, the
height was 11 cm constantly. This phantom was used for
absolute dose measurements at the dose reference point,
for profile measurements at a depth of half height, and
for measurements of the lung shield transmission. Mea-
surements in the phantom were performed using a Uni-
dos dosimeter (PTW, Freiburg, Germany) with an
ionization chamber (IC) M23332, a Roos chamber and
Gafchromic™ EBT3 films (Ashland Inc., Covington, KY,
USA). The films have been scanned by an Epson Perfec-
tion Scanner V700 Photo (Seiko Epson Corp., Nagano,
Japan) and evaluated as described by Maerz et al. [25].
Fig. 1 Linac in starting position and patient setup (Alderson
phantom) on the couch
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The results of the measurements in the stack phantom
were used to create tables for calculations of the MU
and were compared to the RTPS calculations.
A male Alderson phantom (RSD Inc., Long Beach,
CA, USA) equipped with Gafchromic™ films was applied
for final control of the dose distribution.
For in-vivo dosimetry a set of diode detectors (Isorad-p
6-12 MV, Sun Nuclear Corporation, Melbourne, FL, USA),
suitable for TBI dosimetry [26], in combination with a Mul-
tidos electrometer and Multisoft software (PTW, Freiburg,
Germany) has been calibrated against the Unidos dosimeter
in the phantom of 21 cm of RW3 material in the TBI irradi-
ation geometry. The in-vivo measurements were performed
for the first ten patients with total doses of 4 Gy, 8 Gy,
10 Gy, or 12 Gy in the following points: on the forehead,
neck ventral midline, chest midline, ventral and dorsal pro-
jection of the reference point, abdomen midline, ventral
thigh and ankle. Temperature corrections were performed
according the manual [27], which describes a variation of
0.3 % per degree Celsius. The measured values were com-
pared to the calculations of the RTPS.
Radiotherapy planning
Dose calculations were performed using the collapsed
cone algorithm implemented in the Oncentra® External
Beam planning system, version 4.3 and 4.5 (Elekta Ltd.,
Crawley, UK) which calculates dose to medium, introdu-
cing some workarounds:
 The patient is treated in supine and prone position.
Although calculations on the supine study neglect
changes in the body geometry induced by the prone
positioning, it is more descriptive to have the
complete calculations in one study.
 Rotational fields in the RTPS are approximated by
stationary fields separated by 5° gantry difference. At
the large distance of the patient this results in
calculation artefacts. Consequently we always
calculate five arcs with different starting points
shifted 1°, thus getting a resolution of 1°. The MU
are adjusted for the actually delivered eight arcs.
 Dose calculation in Oncentra is only possible for
beams with the central axis intersecting the patient
outline. To overcome this restriction, the patient
outline is extended in cranial and caudal direction
with density of air.
 In Oncentra absorbers can be modelled in accessory
tray only and not on the distant polycarbonate plate.
Therefore doses to the lung and thorax region have
to be corrected manually when shields are applied.
Table 1 Parameters of the fixed beam fields (according IEC 61217 [36])
Field Gantry Angle Collimator Angle Wedge X1 X2 Y1 Y2 Monitor Units
Cranial 330° 270° 60° −16.0 16.0 −14.5 14.5 316
Caudal 1 36° 90° No −16.0 16.0 −8.0 20.0 60
Caudal 2 36° 90° 60° −16.0 16.0 −15.0 15.0 268
Caudal 3 36° 90° No −16.0 16.0 −15.0 20.0 50
Fig. 2 Profiles along the main axis measured with ionization chamber in a cuboid phantom for three different heights. Starting from position
135 cm to the right the height is 11 cm in all three cases. The dose is normalized at position 60 cm. For the standard height of 21 cm a
measurement with Gafchromic™ film and the RTPS calculation are demonstrated
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 As the polycarbonate plate above the patient is not
part of the CT scan, it has to be modelled different:
a simple and fast procedure is adding a flap of 1 cm
to the patient outline [15].
 The actual CT scanner Somatom Sensation
(Siemens, Erlangen, Germany) is designed for
maximum scan lengths of 150 cm. For larger
patients the last scanned slice in the legs must be
extended to the patient’s full body length by tools of
the RTPS and therefore does not represent the
actual geometry of the feet. Using a whole body
spiral CT scanner (commonly used for primary
diagnostics of poly trauma patients [28]) avoids this
workaround.
Although the lung shields cannot be calculated for ro-
tational fields, the RTPS is used for the generation of the
blocks. A gantry position of 350° was found as mean
value of entry and exit of the arc over the lungs. At this
position block contours are generated by the radiation
therapist. The dimensions are adapted to actual position
on the polycarbonate plate.
Lung shields are only applied for a reference dose lar-
ger than 8 Gy. They are used as partial shield to reduce
the total dose to the center of the lung Dt,Lu to 3.5 Gy in
supine and prone position each, giving a total dose of
7 Gy for therapy regimen of 10 and 12 Gy. To evaluate
the transmittance dependent on the material thickness
of the alloy MCP96 three shields of 5, 10 and 20 mm
were combined to blocks up to 35 mm in steps of
5 mm. The measurements were performed in the water
equivalent phantom at a thickness of 21 cm.
The electron fields for the shielded region of the thor-
acic wall are treated once a day, delivering a total dose
De of 3 Gy for the 10 Gy patients and 5 Gy for the
12 Gy patients respectively. The electron fields are
planned with the RTPS Oncentra. The applicability of
the Monte Carlo code in Oncentra has been evaluated
earlier [29, 30]. The calculated percentage dose of the
electron fields pe in the center of the lung is used to
Table 2 Dependency of the number of MU for a given dose value on the phantom height
Stack height in cm 11 13 15 17 19 21 23 25 27 29
Normalized number of MU 95 % 95 % 97 % 98 % 99 % 100 % 101 % 103 % 104 % 106 %
Fig. 3 Transmittance of the lung shields as a function of the thickness of the MCP96 material. The dots represent the measured values, the line
an exponential fit
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calculate the thickness of the lung shields for the photon
arc fields.
The thickness of the lung shields is derived from the
dose calculated by the RTPS for the rotational fields
without shields Dx,Lu and the dose contribution of the
electron fields. The transmittance T is then given by
Eq. 1:




Profiles and absolute dose measurements
Figure 2 shows the profiles in the cuboid phantom for
three different heights, the reference height (21 cm) and
the intended minimum (11 cm) and maximum (29 cm)
heights with an identical height of 11 cm for positions
l ≥ 135 cm as described above. The normalization point
is at position l = 60 cm. Down to position l = 120 cm
which includes the head and trunk region, all values ex-
cept one—at position l = 15 cm for a height of 29 cm at
94 %—are within 95–107 %. Only for the most distant
position at l = 190 cm the dose drops below 90 %.
The longitudinal profiles in the reference phantom
(height 21 cm), measured with Gafchromic™ film and
calculated with the RTPS are included in Fig. 2. Spikes
appear at the borders of the single films as artifacts at
the film edges. Additionally, profiles in different depths
have been determined with films, showing a very similar
behavior.
The absolute dose in the reference point has been de-
termined in the same phantom, using stacks of heights
from 11 to 29 cm in steps of 2 cm. Table 2 shows the
normalized number of MU referring to the reference
stack of 21 cm.
Lung shields and dose rate
The measurement of lung shields of different thickness
of the MCP 96 material shows a range of the transmit-
tance from 80.8 % at 5 mm thickness to 32.0 % at
35 mm. Figure 3 demonstrates the transmittance as a
function of the thickness. When the arc field passes the
Fig. 4 Gamma evaluations of three Gafchromic films in the Alderson phantom (a head region, b thorax, c abdomen) compared to the RTPS
calculations. Read pixels do not fulfill the gamma criterion (3 mm, 3 %). Below the corresponding CT slices
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chamber in the reference stack the dose rate is 0.55 Gy/
min for unshielded fields. Taking the total time into ac-
count, to deliver the arc beams, including the time to
turn the patient from the prone to the supine position,
the average dose rate is about 0.04 Gy/min.
Dose calculations and Alderson and in-vivo
measurements
The MU calculated by the RTPS and the table showed
good agreement within 0.7 % ± 2.1 % (sample standard
deviation).
The films in the Alderson phantom were compared to
the corresponding slices of the RTPS calculations.
Figure 4 shows the gamma evaluations (3 mm, 3 %). In
the red pixels the gamma criterion is not fulfilled. The
red margin emerges from the flap surrounding the phan-
tom in the calculation. The positions of the bores in the
phantom slices, which are used for the connecting rods
appear also in red.
Figure 5 presents dose volume histograms (DVH) of
the inhomogeneous Alderson phantom—which lacks the
limbs—and of one representative patient with similar di-
mensions. Equivalent regions have been marked for
comparison: The head and trunk region which for the
Alderson phantom is the whole outline, and the lungs.
The lungs have been combined to one volume as de-
scribed by the German guideline [21]. The mean dose to
the lungs is about 3 % higher than the mean dose to the
complete phantom outline.
Table 3 contains the average and standard deviation of
the measured dose values of the in-vivo dosimetry.
Comparing these values to the results of the RTPS the
deviation is 0.5 ± 4.7 %. The values for the legs were not
considered in this comparison, due to the short scanning
length of the CT scanner. The measurement points “ref-
erence ventral” and “reference dorsal” do not represent
the reference point, but are only its vertical projection to
the skin. Therefore the values are higher than the refer-
ence dose.
Discussion
The irradiation technique is simple and does not require
any accessories except of the couch on the floor with the
Makrolon® plate on top. Each standard linac is suitable
for the technique. No additional modules for variable
MU per degree are necessary. Treatment rooms of
standard size can be used as it has also been pointed out
recently [17, 31] for a sweeping beam technique with
modulated arcs. The RTPS is essential only for the
Fig. 5 DVH of the Alderson phantom and a representative patient, containing the lungs as organs at risk and the combined head and
trunk region
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electron field calculations, and can be relinquished for
treatments up to 8 Gy total dose. This has been verified
by the very good agreement of the number of MU calcu-
lated by the RTPS and by the table. However,
optimization of the dose distribution is possible by vari-
ation of the field parameters or additional fields and will
further be investigated. The calculations should be pos-
sible with each RTPS, which allows rotational fields at
larger distances. Nevertheless, commissioning for these
non-standard conditions must be performed.
It has been stated in the section about radiotherapy
planning that the planning system cannot handle the lung
shields. Therefore a cumulative DVH of the real lung dose
cannot be presented for the patient groups with 10 Gy
total dose or higher. For patients without lung shields the
DVH of the Alderson phantom and of one representative
patient (Fig. 5) demonstrate a dose distribution to the
body which is in the range described by Quast [11]. The
mean dose to the lungs is higher for about 3 % in the
phantom and similar in the patient due to the lower at-
tenuation of the lung tissue. The calculated values are sup-
ported by the 2D film verification (Fig. 4).
It has been mentioned in the material and methods
section that the dose rate has been chosen to achieve
similar results as with the former technique regarding
the lung toxicity. Furthermore effects of the dose rate on
renal dysfunction have been discussed [32]. Recent pub-
lications confirm the pulmonary toxicity of TBI [2, 33,
34], but Sampath et al. doubt the dependency on the
dose rate [35]. Consequently a large variety of applied
dose rates has been reported [3]. Our current average
value is close to the lower end of the reported range
leading to total treatment times of about one hour per
fraction or even more, if lung shields have to be posi-
tioned. However, reducing the number of arcs and in-
creasing the delivered dose rate is possible to shorten
the treatment times to about half an hour.
The in-vivo measurements with diodes are well in the
range of accepted discrepancies between calculated and
measured dose of the survey of Giebel et al. [3] of up to
10 %. Ramm et al. [26] have used the same type of detec-
tors for over ten years in TBI treatments. However, they
report an influence of less than 0.5 % of the temperature
on the measured value and neglect it, which is not in ac-
cordance with our observations.
Conclusion
We have established a treatment technique for TBI with
standard linacs in standard treatment rooms. Having
similar parameters as with the former treatment ma-
chines, the current treatments can build on an experi-
ence of nearly two decades in our department.
Abandoning any attachments allows the commissioning
of the method without additional certifications and en-
ables the calculation of three-dimensional dose distribu-
tions with a commercial RTPS.
Abbreviations
DVH, dose volume histograms; IC, ionization chamber; Linac, linear
accelerator; MU, monitor units; RTPS, radiotherapy planning system; TBI, total
body irradiation
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